Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • zydus cadila

    Tag: zydus cadila

    You Searched For "zydus cadila"
    Zydus Cadila gets final USFDA nod for Leflunomide tablets to treat arthritis

    Zydus Cadila gets final USFDA nod for Leflunomide tablets to treat arthritis

    Farhat Nasim26 April 2019 12:49 PM IST
    Leflunomide tablet is used to treat rheumatoid arthritis, a condition affecting multiple small and large joints of the body.New Delhi: Drug firm Zydus...
    Zydus Cadila gets USFDA nod for Phentermine Hydrochloride orally disintegrating tablets

    Zydus Cadila gets USFDA nod for Phentermine Hydrochloride orally disintegrating tablets

    Medical Dialogues Bureau26 April 2019 8:59 AM IST
    Phentermine Hydrochloride orally disintegrating tablets is used together with diet and exercise to treat obesity (overweight) in people with risk...
    Zydus Cadila gets final USFDA nod to generic version of Diamox for injection

    Zydus Cadila gets final USFDA nod to generic version of Diamox for injection

    Farhat Nasim18 April 2019 10:00 AM IST
    Acetazolamide injection is a generic version of Diamox for injection.New Delhi: Drug firm Zydus Cadila Wednesday said it has received the final nod...
    Zydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemia

    Zydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemia

    Farhat Nasim17 April 2019 9:45 AM IST
    Zydus Cadila Group Chairman Pankaj R Patel said this innovation has the potential to bring about a paradigm shift in the management of CKD patients...
    Zydus Cadila gets tentative USFDA nod to Lacosamide tablets to treat seizures

    Zydus Cadila gets tentative USFDA nod to Lacosamide tablets to treat seizures

    Farhat Nasim8 April 2019 10:00 AM IST
    Lacosamide is an anti convulsant or anti-epileptic drug, used to prevent and control seizures. It works by reducing the spread of seizure activity in...
    Zydus Cadila gets tentative USFDA nod to Tofacitinib tablets for treating arthritis

    Zydus Cadila gets tentative USFDA nod to Tofacitinib tablets for treating arthritis

    Farhat Nasim6 April 2019 3:00 PM IST
    Tofacitinib is used alone or with other medications to treat moderate to severe forms of rheumatoid arthritis, the company said in a BSE filing. New...
    Zydus Cadila gets tentative USFDA nod for Mirabegron ER tablets to treat overactive bladder

    Zydus Cadila gets tentative USFDA nod for Mirabegron ER tablets to treat overactive bladder

    Farhat Nasim2 April 2019 11:50 AM IST
    The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Mirabegron extended-release...
    Kraft Heinz to Sell Indian Brands Complan, Glucon-D, Nycil and Sampriti to Zydus Wellness Limited

    Kraft Heinz to Sell Indian Brands Complan, Glucon-D, Nycil and Sampriti to Zydus Wellness Limited

    Medical Dialogues Bureau25 Oct 2018 10:01 AM IST
    New Delhi: The Kraft Heinz Company announced that it has entered into a definitive agreement to sell Indian brands Complan, Glucon-D, Nycil and...
    Zydus Cadila gets USFDA nod for skin ointment, stomach ailment drug

    Zydus Cadila gets USFDA nod for skin ointment, stomach ailment drug

    Ruby Khatun Khatun28 May 2018 10:30 AM IST
    New Delhi: Zydus Cadila has received final approval from the US health regulator to market Nystatin ointment and Omeprazole and Sodium Bicarbonate...
    Zydus gets USFDA nod for schizophrenia drug

    Zydus gets USFDA nod for schizophrenia drug

    Ruby Khatun Khatun11 Dec 2017 11:00 AM IST
    New Delhi: Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market Clozapine tablets, used in the treatment...
    ICMR in collaboration with Zydus Cadila launches diagnostic kits to detect livestock diseases

    ICMR in collaboration with Zydus Cadila launches diagnostic kits to detect livestock diseases

    Ruby Khatun Khatun1 Dec 2017 10:15 AM IST
    New Delhi: The Indian Council of Medical Research (ICMR) launched diagnostic kits to detect neglected infectious diseases in livestock.The kits have...
    Zydus Cadila gets USFDA nod for blood pressure treatment drug

    Zydus Cadila gets USFDA nod for blood pressure treatment drug

    Ruby Khatun Khatun30 Nov 2017 10:45 AM IST
    New Delhi: Cadila Healthcare said group firm Zydus Cadila has received final approval from the US health regulator to market Candesartan Cilexetil and...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok